Kridhan Infra Limited (KIL) informed bourses that its associate entity Vijay Nirman Company Private Limited (VNC) has bagged an order worth Rs. 174 crore from Central Public Works Department.

BLS International has begun its operations for the French Embassy in Jordan from August 19, 2018, said the company in a filing to the bourses.

We hear a lot the disclaimer that all mutual fund investments are subject to market risk, then what does this market risk mean? Mark-to-market risk is what this disclosure is trying to warn about.

Tech Mahindra has received an approval from its board to acquire 100 per cent shareholding on a fully diluted basis in Inter-Informatics spol.s.r.o., an entity based in the Czech Republic through its wholly-owned subsidiary, Mahindra Engineering Services (Europe).

The Centrum Group is eying to buy L&T Finance’s supply chain lending arm which has an outstanding loan book of Rs. 800 crore. This move is aligned with L&T Finance’s long-term strategy to reduce its wholesale lending business and focus on high yield retail and housing divisions, going forward.

In-line with the government's emphasis on using agriculture waste as industrial fuel, the company's R&D team had developed a product called as Processed Agriculture waste. Reacting to this, the stock of Jiya Eco-Products Limited was trading up by more than 2 per cent on Thursday.

On Thursday, we expect the index to witness a stable opening and see some consolidation. On the upside, the levels of 11,600, followed by 11,640, are likely to act as immediate hurdles for the index. Stocks in news: Lupin, Ultratech Cement, DHFL, Granules, HDFC, Nestle, ITI, Jet Airways, BPCL and Navneet Education.

Today, the markets are likely to make a flat start as the cues from global markets are muted. The SGX Nifty suggests that Nifty could open around 11,623.  

Pharma major Lupin bagged tentative USFDA approval for its generic Nudovra tablets. The company got USFDA approval to market this generic version of Natazia tablet belonging to Bayer Healthcare Pharmaceuticals. The stock of Lupin Limited is off its 52-week low and has witnessed trend reversal, recently.

The US drug regulator has granted Strides’ request to designate the medications under these ANDAs as a Competitive Generic Therapy (CGT). The company's wholly-owned step-down subsidiary, Strides Pharma Global Pte. Limited, Singapore, received the ANDAs.